OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
September 23, 2022
Legislative leaders are looking to approve a bare-bones measure to fund FDA operations as part of a short-term government funding bill.
September 22, 2022
FDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.
September 21, 2022
The Public-Private Partnership for Rare Neurodegenerative Diseases will work to enhance understanding and develop treatments for rare neurodegenerative diseases.
FDA granted accelerated approval to Skysona (elivaldogene autotemcel), which is designed to slow the progression of neurologic dysfunction in adolescents with CALD.
Lonza has expanded its HPAPI multipurpose suite for payload-linker manufacturing.
Boehringer Ingelheim will use Virtuosi to train employees at three aseptic sites across its network.
September 20, 2022
Regulatory officials are addressing challenges in ensuring that clinical data can be relied on in making regulatory decisions.
CytoReason has announced an expanded collaboration deal with Pfizer to deliver AI for drug discovery and development.
Choosing low-adsorption glass vials helps ensure detection accuracy.
Otsuka announced that the EC has approved Lupkynis as the first oral treatment for active lupus nephritis.